サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1392054

胸膜疾患市場：疾患タイプ別、診断ツール別、治療手段別、エンドユーザー別、地域別

Pleural Diseases Market, By Disease Type, By Diagnostic Tools, By Treatment Modalities, By End User, By Geography

出版日
ページ情報
英文 165 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
胸膜疾患市場：疾患タイプ別、診断ツール別、治療手段別、エンドユーザー別、地域別
出版日: 2023年11月02日
発行: Coherent Market Insights
ページ情報: 英文 165 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の胸膜疾患市場規模は、2023年に50億1,000万米ドルと評価され、2023年から2030年までCAGR7.2％で成長し、2030年には81億3,000万米ドルに達すると予測されています。

レポート範囲 レポート詳細
基準年 2022年 2023年の市場規模 50億1,000万米ドル
実績データ 2018年～2021年 予測期間 2023-2030
予測期間のCAGR 7.20% 2030年の市場規模予測 81億3,000万米ドル
図1.胸膜疾患の世界市場シェア（%）、地域別、2023年
Pleural Diseases Market-IMG1

胸膜疾患は、肺を取り囲む薄い膜である胸膜に影響を及ぼす多様な疾患群を包含します。これらの疾患は、呼吸機能や全身の健康に大きな影響を与える可能性があります。胸膜は、潤滑を提供し、呼吸中のスムーズな動きを可能にすることにより、肺の構造と機能の完全性を維持する上で重要な役割を果たしています。胸膜疾患は、感染症、炎症、腫瘍、有害物質への暴露など、さまざまな原因によって生じる可能性があります。一般的な胸膜疾患には、胸膜炎、胸水、気胸、中皮腫などがあります。症状を認識し、正確に診断し、適切な治療戦略を実施することは、これらの課題である世界の胸膜疾患に罹患した患者を管理し、転帰を改善する上で不可欠です。世界の胸膜疾患市場は、喫煙、結核、転移などの関連リスク因子の有病率の上昇に牽引され、長年にわたり着実に成長しています。さらに、画像診断技術やレーザー治療などの診断・治療方法における著しい技術進歩が市場の成長をさらに後押ししています。

市場力学：

合意などの無機的戦略の採用が増加していることも、予測期間中の市場成長を促進すると予想されます。例えば、2020年11月、製薬会社である大鵬薬品工業株式会社と臨床段階のバイオ医薬品会社であるLung Therapeutics, Inc.は、Lung Tx社が現在開発中の遺伝子組換え型ヒト一本鎖ウロキナーゼプラスミノーゲン活性化因子LTI-01の限局性胸水に対する日本領域での独占的ライセンス契約を発表しました。

しかし、認知度の低さや診断の遅れ、診断ツールや治療にかかるコスト、専門知識やリソースの不足などが、予測期間中の世界の胸膜疾患市場の成長を妨げると予想されます。

本調査の主な特徴

  • 本レポートは、世界の胸膜疾患市場を詳細に分析し、2022年を基準年とした予測期間（2023-2030年）の市場規模および複合年間成長率（CAGR %）を提供します。
  • また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場に対する魅力的な投資提案のマトリックスについて解説しています。
  • また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて、世界の胸膜疾患市場の主要企業をプロファイルしています。
  • このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
  • 世界の胸膜疾患市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
  • 利害関係者は、世界の胸膜疾患市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提

  • 調査目的
  • 仮定
  • 略語

第2章 市場展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
  • 呼吸器疾患の罹患率の増加
    • 抑制要因
  • 利用できる専門知識とリソースが限られている
    • 機会
  • 新興バイオマーカーと精密医療
  • 影響分析
  • 主なハイライト
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • ポーターの分析
  • 合併と買収のシナリオ

第4章 世界の胸膜疾患市場- コロナウイルス（COVID-19）パンデミックの影響

  • 新型コロナウイルス感染症（COVID-19）の疫学
  • 供給側と需要側の分析
  • 経済的影響

第5章 世界の胸膜疾患市場、疾患タイプ別、2018～2030年

  • 胸膜炎
  • 胸水
  • 肺皮腫
  • 中皮腫
  • その他

第6章 世界の胸膜疾患市場、診断ツール別、2018～2030年

  • イメージング技術
  • 分子診断学
  • 胸腔鏡検査と胸膜鏡検査

第7章 世界の胸膜疾患市場、治療手段別、2018～2030年

  • 薬
  • 胸腔穿刺と胸膜癒着術
  • 低侵襲介入
  • 外科的介入

第8章 世界の胸膜疾患市場、エンドユーザー別、2018～2030年

  • 病院と診療所
  • 診断センター
  • 研究および学術機関

第9章 世界の胸膜疾患市場、地域別、2018-2030年

  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東
  • アフリカ

第10章 競合情勢

  • Bristol Myers Squibb
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Boehringer Ingelheim International GmbH
  • Sanofi
  • AbbVie Inc.
  • Braun SE
  • Becton, Dickinson and Company
  • Bicakcilar
  • Biometrix
  • Cook Medical
  • Grena
  • Redax
  • Rocket Medical
  • Smith Medical

第11章 セクション

  • 調査手法
  • 出版社について
目次
Product Code: CMI6038

The Global Pleural Diseases Market size was valued at US$ 5.01 Bn in 2023 and is expected to reach US$ 8.13 Bn by 2030, growing at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 5.01 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 7.20% 2030 Value Projection: US$ 8.13 Bn
Figure 1. Global Pleural Diseases Market Share (%), By Region, 2023
Pleural Diseases Market - IMG1

Pleural diseases encompass a diverse group of conditions affecting the pleura, the thin membrane surrounding the lungs. These conditions can significantly impact respiratory function and overall well-being. The pleura plays a crucial role in maintaining the integrity of the lung's structure and function by providing lubrication and allowing smooth movement during breathing. Pleural diseases can arise from various causes, including infections, inflammation, tumors, and exposure to hazardous substances. Common pleural disorders include pleurisy, pleural effusion, pneumothorax and mesothelioma. Recognizing the symptoms, diagnosing accurately, and implementing appropriate treatment strategies are essential in managing and improving outcomes for individuals affected by these challenging global pleural diseases. The global global pleural diseases market has been steadily growing over the years driven by the rising prevalence of associated risk factors such as smoking, tuberculosis, and metastases. Furthermore, the market has witnessed significant technological advancements in diagnosis and treatment modalities such as imaging techniques and laser therapy, further supporting the market growth.

Market Dynamics:

The increasing adoption of inorganic strategies such as agreement is also expected to drive the growth of the market over the forecast period. For instance, in November 2020, Taiho Pharmaceutical Co., Ltd, a pharmaceutical company, and Lung Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced an exclusive license agreement of LTI-01, a recombinant human single-chain urokinase plasminogen activator, currently under development by Lung Tx for loculated pleural effusions, for the territory of Japan.

However, limited awareness and delayed diagnosis, cost of diagnostic tools and treatment, limited availability of expertise and resources are expected to hamper growth of the global pleural diseases market over the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the global pleural diseases market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Global Pleural Diseases market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pleural diseases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural diseases market

Global Pleural Diseases Market Segmentation Detailed Segmentation:

  • By Disease Types:
    • Pleurisy
    • Pleural Effusion
    • Pneumothelioma
    • Mesothelioma
    • Others
  • By Diagnostic Tools:
    • Imaging Techniques
    • Molecular Diagnostics
    • Thoracoscopy and Pleuroscopy
  • By Treatment Modalities:
    • Medications
    • Thoracentesis and Pleurodesis
    • Minimally Invasive Interventions
    • Surgical Interventions
  • By End User:
    • Hospitals and Clinics
    • Diagnostic Centers
    • Research and Academic Institutions
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • Bristol Myers Squibb
    • Merck & Co., Inc.
    • GlaxoSmithKline plc
    • Boehringer Ingelheim International GmbH
    • Sanofi
    • AbbVie Inc.
    • Braun SE
    • Becton, Dickinson and Company
    • Bicakcilar
    • Biometrix
    • Cook Medical
    • Grena
    • Redax
    • Rocket Medical
    • Smith Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Pleural Diseases, By Disease Type
    • Market Pleural Diseases, By Diagnostic Tools
    • Market Pleural Diseases, By Treatment Modalities
    • Market Pleural Diseases, By End User
    • Market Pleural Diseases, By Geography/Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing Prevalence of Respiratory diseases
    • Restraints
  • Limited Availability of Expertise and Resources
    • Opportunities
  • Emerging Biomarkers and Precision Medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Pleural Diseases Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Pleural Diseases Market, By Disease Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Pleurisy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Pleural Effusion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Pneumothelioma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Mesothelioma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Pleural Diseases Market, By Diagnostic Tools, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Imaging Techniques
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Molecular Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 20218-2030, (US$ Billion)
  • Thoracoscopy and Pleuroscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Pleural Diseases Market, By Treatment Modalities, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Medications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Thoracentesis and Pleurodesis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Minimally Invasive Interventions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Surgical Interventions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Pleural Diseases Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Research and Academic Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

9. Global Pleural Diseases Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Tools, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modalities, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)

10. Competitive Landscape

  • Bristol Myers Squibb
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GlaxoSmithKline plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Braun SE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bicakcilar
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biometrix
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cook Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Grena
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Redax
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Rocket Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Smith Medical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us